Minerva Neurosciences, Inc.
NERV
$7.85
$0.010.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 4.64M | 4.64M | 7.21M | 10.01M | 12.75M |
| Gross Profit | -4.64M | -4.64M | -7.21M | -10.01M | -12.75M |
| SG&A Expenses | 9.07M | 9.63M | 9.98M | 9.95M | 9.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.64M | 16.17M | 19.07M | 21.85M | 24.50M |
| Operating Income | -14.64M | -16.17M | -19.07M | -21.85M | -24.50M |
| Income Before Tax | -14.03M | 11.23M | 6.25M | 1.44M | -3.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.03 | 11.23 | 6.25 | 1.44 | -3.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.03M | 11.23M | 6.25M | 1.44M | -3.31M |
| EBIT | -14.64M | -16.17M | -19.07M | -21.85M | -24.50M |
| EBITDA | -14.64M | -16.16M | -19.06M | -21.84M | -24.49M |
| EPS Basic | -1.85 | 1.48 | 0.83 | 0.19 | -0.44 |
| Normalized Basic EPS | -1.16 | 0.93 | 0.52 | 0.12 | -0.27 |
| EPS Diluted | -1.85 | 1.48 | 0.82 | 0.19 | -0.44 |
| Normalized Diluted EPS | -1.16 | 0.93 | 0.52 | 0.12 | -0.27 |
| Average Basic Shares Outstanding | 30.28M | 30.28M | 30.28M | 30.28M | 30.28M |
| Average Diluted Shares Outstanding | 30.28M | 30.28M | 30.28M | 30.28M | 30.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |